ClearPoint Neuro (CLPT) Other Non-Current Assets (2011 - 2026)
ClearPoint Neuro (CLPT) reported Other Non-Current Assets of $1.6 million for Q1 2026, up 1012.16% on a YoY basis from $148000.0 in Q1 2025, and down 3.29% sequentially from $1.7 million in Q4 2025.
ClearPoint Neuro (CLPT) Other Non-Current Assets (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 16 years of Other Non-Current Assets data on file, last reported at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 1012.16% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 1012.16% YoY), and the FY2025 full-year result was $1.7 million, up 131.56% from the prior year.
- Other Non-Current Assets slipped to $1.6 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.7 million in Q4 2025 to a low of $94000.0 in Q1 2022.
- A 5-year average of $427882.4 and a median of $148000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets plunged 37.75% in 2022 and jumped 1012.16% in 2026, its largest moves.
- Tracing CLPT's Other Non-Current Assets over 5 years: stood at $131000.0 in 2022, then retreated by 16.79% to $109000.0 in 2023, then soared by 574.31% to $735000.0 in 2024, then soared by 131.56% to $1.7 million in 2025, then declined by 3.29% to $1.6 million in 2026.
- Business Quant data shows CLPT's Other Non-Current Assets at $1.6 million in Q1 2026, $1.7 million in Q4 2025, and $959000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 959,000.00 |
| Jun 30, 2025 | 720,000.00 |
| Mar 31, 2025 | 148,000.00 |
| Dec 31, 2024 | 735,000.00 |
| Sep 30, 2024 | 148,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Dec 31, 2023 | 109,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Jun 30, 2023 | 156,000.00 |
| Mar 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Sep 30, 2022 | 94,000.00 |
| Jun 30, 2022 | 94,000.00 |
| Mar 31, 2022 | 94,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 86,000.00 |
| Jun 30, 2021 | 151,000.00 |